Skip to main content
Top
Published in: International Orthopaedics 10/2013

01-10-2013 | Original Paper

Surgical resection and radiation therapy of desmoid tumours of the extremities: results of a supra-regional tumour centre

Authors: Peter Michael Prodinger, Hans Rechl, Matthias Keller, Hakan Pilge, Maya Salzmann, Ruediger von Eisenhart-Rothe, Boris Michael Holzapfel

Published in: International Orthopaedics | Issue 10/2013

Login to get access

Abstract

Purpose

Desmoid tumours of the extremity have a high recurrence rate. The purpose of this study was to analyse the outcome after resection of these tumours with special emphasis on recurrent disease and adjuvant therapeutic strategies.

Methods

In this retrospective study we evaluated prognostic factors for recurrence-free survival after surgical treatment of desmoid tumours of the extremity in 27 patients with an average age of 41 years treated from 1997 to 2009. Adjuvant radiotherapy (50–60 Gy) was given in five cases with primary and in nine patients with recurrent disease. The average follow-up was 64 months.

Results

The five-year recurrence-free survival in patients with primary disease was 33 %. Patients with negative resection margins tended to have a better outcome than patients with positive resection margins, but the difference between both groups was not significant (56 vs 14 %, p = 0.145). In patients with positive margins, adjuvant radiotherapy did not significantly improve recurrence-free survival (40 vs 14 %, p = 0.523). Patients with local recurrence had a five-year further recurrence-free survival of 47 %. In those patients further recurrence-free survival was significantly better after adjuvant radiation (89 vs 25 %, p = 0.015). Two thirds of all patients suffered moderate or severe complications due to the treatment regimen.

Conclusions

Compared to desmoids of the trunk or the head and neck region, desmoids affecting the limbs show by far the worst outcome in terms of relapse or treatment-related morbidity. The importance of negative resection margins is still not clear. Particularly in recurrent desmoids adjuvant radiotherapy appears to reduce the further recurrence rate. Therefore, a general use of radiation should be considered for this high-risk group.
Literature
1.
go back to reference Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569PubMedCrossRef Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569PubMedCrossRef
2.
go back to reference Piza-Katzer H, Rhomberg M (2000) Extra-abdominal fibromatosis–extra-abdominal desmoid. Review and personal experiences. Chirurg 71:904–911PubMedCrossRef Piza-Katzer H, Rhomberg M (2000) Extra-abdominal fibromatosis–extra-abdominal desmoid. Review and personal experiences. Chirurg 71:904–911PubMedCrossRef
3.
go back to reference Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17:158–167PubMed Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 17:158–167PubMed
4.
go back to reference Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M, Rosai J (2003) Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21:1390–1397PubMedCrossRef Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, Bertulli R, Fiore M, Olmi P, Santinami M, Rosai J (2003) Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 21:1390–1397PubMedCrossRef
5.
go back to reference Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25:1785–1791PubMedCrossRef Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE (2007) Optimizing treatment of desmoid tumors. J Clin Oncol 25:1785–1791PubMedCrossRef
6.
go back to reference Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF (1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86:2045–2052PubMedCrossRef Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF (1999) Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer 86:2045–2052PubMedCrossRef
7.
go back to reference Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT, Suit HD (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40:637–645PubMedCrossRef Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS, Gebhardt MC, Rosenberg AE, Efird JT, Suit HD (1998) Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys 40:637–645PubMedCrossRef
8.
go back to reference Fletcher CD (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48:3–12PubMedCrossRef Fletcher CD (2006) The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 48:3–12PubMedCrossRef
9.
go back to reference Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14:181–190PubMedCrossRef Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS (2003) The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 14:181–190PubMedCrossRef
10.
go back to reference Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374PubMed Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC (1984) Extra-abdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374PubMed
11.
go back to reference Melis M, Zager JS, Sondak VK (2008) Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98:594–602PubMedCrossRef Melis M, Zager JS, Sondak VK (2008) Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 98:594–602PubMedCrossRef
12.
go back to reference Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd (2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 88:1517–1523PubMedCrossRef Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd (2000) Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 88:1517–1523PubMedCrossRef
13.
go back to reference Mankin HJ, Hornicek FJ, Springfield DS (2010) Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol 102:380–384PubMedCrossRef Mankin HJ, Hornicek FJ, Springfield DS (2010) Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol 102:380–384PubMedCrossRef
14.
go back to reference Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, Bonvalot S, Stoeckle E, Guillou L, Le Cesne A, Oberlin O, Brouste V, Coindre JM (2011) Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 29:3553–3558PubMedCrossRef Salas S, Dufresne A, Bui B, Blay JY, Terrier P, Ranchere-Vince D, Bonvalot S, Stoeckle E, Guillou L, Le Cesne A, Oberlin O, Brouste V, Coindre JM (2011) Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 29:3553–3558PubMedCrossRef
15.
go back to reference Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665PubMedCrossRef Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, Juillard GJ, Selch MT (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665PubMedCrossRef
16.
go back to reference Compton CC (2012) Soft tissue sarcoma. In: Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzmann SH, Olawaiye A, Washington MK (eds) AJCC cancer staging atlas. A companion to the seventh editions of the AJCC cancer staging manual and handbook. Springer, New York Compton CC (2012) Soft tissue sarcoma. In: Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzmann SH, Olawaiye A, Washington MK (eds) AJCC cancer staging atlas. A companion to the seventh editions of the AJCC cancer staging manual and handbook. Springer, New York
17.
go back to reference Barbier O, Anract P, Pluot E, Larouserie F, Sailhan F, Babinet A, Tomeno B (2010) Primary or recurring extra-abdominal desmoid fibromatosis: assessment of treatment by observation only. Orthop Traumatol Surg Res 96:884–889PubMedCrossRef Barbier O, Anract P, Pluot E, Larouserie F, Sailhan F, Babinet A, Tomeno B (2010) Primary or recurring extra-abdominal desmoid fibromatosis: assessment of treatment by observation only. Orthop Traumatol Surg Res 96:884–889PubMedCrossRef
18.
go back to reference Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A, Le Pechoux C (2008) Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 34:462–468PubMedCrossRef Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A, Le Pechoux C (2008) Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 34:462–468PubMedCrossRef
19.
go back to reference Sørensen A, Keller J, Nielsen OS, Jensen OM (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 73:213–219PubMedCrossRef Sørensen A, Keller J, Nielsen OS, Jensen OM (2002) Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand 73:213–219PubMedCrossRef
20.
go back to reference Stoeckle E, Coindre JM, Longy M, Binh MB, Kantor G, Kind M, de Lara CT, Avril A, Bonichon F, Bui BN (2009) A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 35:129–134PubMedCrossRef Stoeckle E, Coindre JM, Longy M, Binh MB, Kantor G, Kind M, de Lara CT, Avril A, Bonichon F, Bui BN (2009) A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 35:129–134PubMedCrossRef
21.
go back to reference Pritchard DJ, Nascimento AG, Petersen IA (1996) Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 78:848–854PubMed Pritchard DJ, Nascimento AG, Petersen IA (1996) Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 78:848–854PubMed
22.
go back to reference Huang K, Fu H, Shi YQ, Zhou Y, Du CY (2009) Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol 100:563–569PubMedCrossRef Huang K, Fu H, Shi YQ, Zhou Y, Du CY (2009) Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol 100:563–569PubMedCrossRef
23.
go back to reference Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF (1999) The enigma of desmoid tumors. Ann Surg 229:866–872, discussion 872–863PubMedCrossRef Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF (1999) The enigma of desmoid tumors. Ann Surg 229:866–872, discussion 872–863PubMedCrossRef
24.
go back to reference Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF (1989) The desmoid tumor. Not a benign disease. Arch Surg 124:191–196PubMedCrossRef Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF (1989) The desmoid tumor. Not a benign disease. Arch Surg 124:191–196PubMedCrossRef
25.
go back to reference Reitamo JJ, Scheinin TM, Häyry P (1986) The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151:230–237PubMedCrossRef Reitamo JJ, Scheinin TM, Häyry P (1986) The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg 151:230–237PubMedCrossRef
Metadata
Title
Surgical resection and radiation therapy of desmoid tumours of the extremities: results of a supra-regional tumour centre
Authors
Peter Michael Prodinger
Hans Rechl
Matthias Keller
Hakan Pilge
Maya Salzmann
Ruediger von Eisenhart-Rothe
Boris Michael Holzapfel
Publication date
01-10-2013
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 10/2013
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-013-1942-1

Other articles of this Issue 10/2013

International Orthopaedics 10/2013 Go to the issue